{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:50:15Z","timestamp":1795027815998,"version":"4.10.2"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Macrophage polarization anomalies and dysfunction play a crucial role in the pathogenesis of immune thrombocytopenia (ITP). Itaconate is a Krebs cycle-derived immunometabolite synthesized by myeloid cells to modulate cellular metabolism and inflammatory responses. This study aimed to evaluate the immunoregulatory effects of an itaconate derivative on macrophages in patients with ITP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Peripheral blood-derived macrophages from patients with ITP and healthy controls were treated with 4-octyl itaconate (4-OI), a derivative of itaconate that can penetrate the cell membrane. Macrophage polarization, antigen-presenting functions, and phagocytic capability were measured via flow cytometry and enzyme-linked immunosorbent assay (ELISA). Macrophage glycolysis in patients with ITP and the metabolic regulatory effect of 4-OI were detected using a Seahorse XFe96 Analyzer. An active murine model of ITP was used to evaluate the therapeutic effects of 4-OI <jats:italic toggle=\"yes\">in vivo<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>4-OI reduced the levels of CD80 and CD86 in M1 macrophages and suppressed the release of tumor necrosis factor-\u03b1 (TNF-\u03b1) and interleukin (IL)-6 pro-inflammatory cytokines, suggesting that 4-OI could hinder the polarization of macrophages toward an M1 phenotype. We found that 4-OI pretreated M1 macrophages reduced the proliferation of CD4<jats:sup>+<\/jats:sup> T cells and promoted the differentiation of regulatory T cells. In addition, after 4-OI treatment, the phagocytic capacity of M1 macrophages toward antibody-coated platelets decreased significantly in patients with ITP. In addition, the glycolytic function of M1 macrophages was elevated in individuals with ITP compared to those in healthy controls. 4-OI treatment downregulated glycolysis in M1 macrophages. The glycolysis inhibitor 2-deoxy-d-glucose (2-DG) also inhibited the polarization of M1 macrophages and restored their functions. <jats:italic toggle=\"yes\">In vivo<\/jats:italic>, 4-OI treatment significantly increased platelet counts in the active ITP murine model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Itaconate derivative 4-OI inhibited M1 macrophage polarization and restored impaired functions through metabolic reprogramming. This study provides a novel therapeutic option for ITP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003586","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:01:01Z","timestamp":1748476861000},"page":"2006-2015","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Itaconate derivative 4-OI inhibits M1 macrophage polarization and restores its impaired function in immune thrombocytopenia through metabolic reprogramming"],"prefix":"10.1097","volume":"138","author":[{"given":"Qiang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqiu","family":"Leng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shandong Key Laboratory of Immunochematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012,China"},{"name":"Department of Clinical Laboratory, Qilu Hospital (Qingdao) of Shandong University, Qingdao, Shandong 266035, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012,China"},{"name":"Shandong Key Laboratory of Immunochematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012,China"},{"name":"Shandong Key Laboratory of Immunochematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"R1-20250821","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"R2-20250821","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N Engl J Med"},{"key":"R3-20250821","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bjh.19083","article-title":"Pathogenesis of refractory ITP: Overview","volume":"203","author":"Cines","year":"2023","journal-title":"Br J Haematol"},{"key":"R4-20250821","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/ijms25042163","article-title":"Current understanding of immune thrombocytopenia: A review of pathogenesis and treatment options","volume":"25","author":"Mititelu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R5-20250821","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"key":"R6-20250821","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00277-008-0535-3","article-title":"Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura","volume":"87","author":"Ma","year":"2008","journal-title":"Ann Hematol"},{"key":"R7-20250821","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0609.2003.00138.x","article-title":"High Th1\/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura","volume":"71","author":"Ogawara","year":"2003","journal-title":"Eur J Haematol"},{"key":"R8-20250821","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2012-02-413526","article-title":"Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia","volume":"120","author":"Aslam","year":"2012","journal-title":"Blood"},{"key":"R9-20250821","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2008-01-135335","article-title":"Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura","volume":"112","author":"Yu","year":"2008","journal-title":"Blood"},{"key":"R10-20250821","first-page":"2417","article-title":"The role of CD8+ T-cell clones in immune thrombocytopenia","volume":"141","author":"Malik","year":"2023","journal-title":"Blood"},{"key":"R11-20250821","doi-asserted-by":"crossref","first-page":"27445","DOI":"10.1038\/srep27445","article-title":"CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci Rep"},{"key":"R12-20250821","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3324\/haematol.12889.","article-title":"Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies","volume":"93","author":"Zhao","year":"2008","journal-title":"Haematologica"},{"key":"R13-20250821","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"R14-20250821","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"R15-20250821","doi-asserted-by":"crossref","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"R16-20250821","doi-asserted-by":"crossref","first-page":"8821610","DOI":"10.1155\/2023\/8821610","article-title":"Regulatory mechanism of M1\/M2 macrophage polarization in the development of autoimmune diseases","volume":"2023","author":"Peng","year":"2023","journal-title":"Mediators Inflamm"},{"key":"R17-20250821","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R18-20250821","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0040-1722186","article-title":"Tumor necrosis factor-alpha blockade corrects monocyte\/macrophage imbalance in primary immune thrombocytopenia","volume":"121","author":"Zhao","year":"2021","journal-title":"Thromb Haemost"},{"key":"R19-20250821","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1016\/S2352-3026(21)00240-4","article-title":"All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: A multicentre, open-label, randomised, controlled, phase 2 trial","volume":"8","author":"Huang","year":"2021","journal-title":"Lancet Haematol"},{"key":"R20-20250821","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/jth.13767","article-title":"High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia","volume":"15","author":"Feng","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R21-20250821","doi-asserted-by":"crossref","first-page":"880286","DOI":"10.3389\/fimmu.2022.880286","article-title":"Effects of metabolism on macrophage polarization under different disease backgrounds","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"R22-20250821","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/08830185.2014.969421","article-title":"Cellular metabolism and macrophage functional polarization","volume":"34","author":"Zhu","year":"2015","journal-title":"Int Rev Immunol"},{"key":"R23-20250821","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front Immunol"},{"key":"R24-20250821","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1042\/BST20150107","article-title":"Metabolic signatures linked to macrophage polarization: From glucose metabolism to oxidative phosphorylation","volume":"43","author":"Bosca","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"R25-20250821","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res"},{"key":"R26-20250821","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-20250821","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/imr.12838","article-title":"Immunometabolism in the development of rheumatoid arthritis","volume":"294","author":"Weyand","year":"2020","journal-title":"Immunol Rev"},{"key":"R28-20250821","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1073\/pnas.1218599110","article-title":"Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production","volume":"110","author":"Michelucci","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-20250821","doi-asserted-by":"crossref","first-page":"102553","DOI":"10.1016\/j.redox.2022.102553","article-title":"The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases","volume":"58","author":"Shi","year":"2022","journal-title":"Redox Biol"},{"key":"R30-20250821","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.it.2019.05.007","article-title":"The immunomodulatory potential of the metabolite itaconate","volume":"40","author":"Hooftman","year":"2019","journal-title":"Trends Immunol"},{"key":"R31-20250821","doi-asserted-by":"crossref","first-page":"e148548","DOI":"10.1172\/JCI148548","article-title":"The role of itaconate in host defense and inflammation","volume":"132","author":"Peace","year":"2022","journal-title":"J Clin Invest"},{"key":"R32-20250821","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1159\/000495400","article-title":"4-Octyl itaconate activates Nrf2 signaling to inhibit pro-inflammatory cytokine production in peripheral blood mononuclear cells of systemic lupus erythematosus patients","volume":"51","author":"Tang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R33-20250821","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cmet.2020.07.016","article-title":"The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation","volume":"32","author":"Hooftman","year":"2020","journal-title":"Cell Metab"},{"key":"R34-20250821","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"key":"R35-20250821","doi-asserted-by":"crossref","first-page":"14274","DOI":"10.1074\/jbc.M115.685792","article-title":"Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels","volume":"291","author":"Cordes","year":"2016","journal-title":"J Biol Chem"},{"key":"R36-20250821","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1038\/s41467-019-13078-5","article-title":"4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects","volume":"10","author":"Liao","year":"2019","journal-title":"Nat Commun"},{"key":"R37-20250821","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"R38-20250821","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2010-07-295477","article-title":"High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia","volume":"117","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"R39-20250821","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood-2009-09-244772","article-title":"A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy","volume":"115","author":"Chow","year":"2010","journal-title":"Blood"},{"key":"R40-20250821","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"R41-20250821","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1038\/s41467-022-34306-5","article-title":"A genetically encoded fluorescent biosensor for detecting itaconate with subcellular resolution in living macrophages","volume":"13","author":"Sun","year":"2022","journal-title":"Nat Commun"},{"key":"R42-20250821","first-page":"5404780","article-title":"Itaconate: a metabolite regulates inflammation response and oxidative stress","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R43-20250821","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","article-title":"Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages","volume":"34","author":"Runtsch","year":"2022","journal-title":"Cell Metab"},{"key":"R44-20250821","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"key":"R45-20250821","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","article-title":"Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura","volume":"78","author":"Liu","year":"2007","journal-title":"Eur J Haematol"},{"key":"R46-20250821","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41589-019-0323-5","article-title":"S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate","volume":"15","author":"Qin","year":"2019","journal-title":"Nat Chem Biol"},{"key":"R47-20250821","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/ard-2023-224774","article-title":"Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis","volume":"83","author":"Kachler","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R48-20250821","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10753-024-02050-1","article-title":"4-Octyl itaconate attenuates neuroinflammation in experimental autoimmune encephalomyelitis via regulating microglia","volume":"48","author":"Zhao","year":"2025","journal-title":"Inflammation"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T04:01:18Z","timestamp":1755748878000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":48,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003586","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"2024-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}